Association between fentanyl use and virologic suppression in an HIV-infected cohort of people who use/inject drugs (PWID): results from a bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) switch study

被引：0
|
作者：
Conway, B. [1 ,2 ]
Yi, S. [1 ]
Sharma, S. [1 ]
Yung, R. [1 ]
Truong, D. [1 ]
机构：
[1] Vancouver Infect Dis Ctr, Vancouver, BC, Canada
[2] Simon Fraser Univ, Burnaby, BC, Canada
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2022年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P127
引用
收藏
页码：121 / 122
页数：2
相关论文
共 43 条
  • [31] First real-life data of tenofovir alafenamide (TAF)-based ART in adult HIV-1-infected patients enrolled in the French TARANIS cohort: results on the use of E/C/F/TAF (Genvoya®)
    Meynard, J.
    Duvivier, C.
    Molina, J.
    Ajana, F.
    Pichancourt, G.
    Morlat, P.
    Revest, M.
    Poizot-Martin, I.
    Hocqueloux, L.
    Janssen, C.
    Genet, P.
    Katlama, C.
    Leclercq, P.
    Haubrich, R.
    Durand, F.
    Sahali, S.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [32] Effectiveness, persistence and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF), rilpivirine/F/TAF (R/F/TAF) or F/TAF + another 3rd agent in HIV-1+patients over 24 months - Results from the German TAFNES cohort study
    Stellbrink, H.
    Scholten, S.
    Hillenbrand, H.
    Knechten, H.
    Jessen, H.
    Schreiber, S.
    Goerner, K.
    Haubrich, R.
    Heinzkill, M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 54 - 55
  • [33] Patient-reported outcome (PRO) measures at 12 months (12M) in a real-world cohort of people living with HIV (PLWH) with a high prevalence of comorbidities receiving bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in Europe, Canada, and Israel
    Brunetta, J.
    Monforte, A. D'Arminio
    Elbirt, D.
    Postel, N.
    van Welzen, B.
    Zeggagh, J.
    Milinkovic, A.
    Marongiu, A.
    Heinzkill, M.
    Thorpe, D.
    Cornejo, A. Torres
    Antela, A.
    HIV MEDICINE, 2021, 22 : 108 - 110
  • [34] Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France: Results from the COSINUS cohort study
    Roux, Perrine
    Faye, Aissatou
    Sagaon-Teyssier, Luis
    Donadille, Cecile
    Madrid, Laelia Briand
    Carrieri, Maria Patrizia
    Maradan, Gwenaelle
    Jauffret-Roustide, Marie
    Lalanne, Laurence
    Auriacombe, Marc
    DRUG AND ALCOHOL REVIEW, 2025, 44 (01) : 275 - 287
  • [35] Doravirine/Islatravir (100mg/0.75mg) once daily compared to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as Initial HIV-1 treatment: 48 week results from a double-blind phase 3 trial
    Rockstroh, J. K.
    Paredes, R.
    Cahn, P.
    Molina, J. -M.
    Sokhela, S.
    Hinestrosa, F.
    Kassim, S.
    Ortega, E. Valencia
    Cunningham, D.
    Ghosn, J.
    Bogner, J. R.
    Gatanaga, H.
    Asante-Appiah, E.
    Zang, Y.
    Klopfer, S. O.
    Eves, K.
    Pisculli, M. L.
    Squires, K.
    Correll, T. A.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2023, 26
  • [36] Association between recent methamphetamine use, antiretroviral therapy and HIV viral load; a mediation analysis from a cohort of HIV positive persons who inject drugs in Hai Phong, Vietnam
    Feelemyer, Jonathan
    Des Jarlais, Don
    Nagot, Nicolas
    Thi, Huong Duong
    Hai, Oanh Khuat Thi
    Minh, Khue Pham
    Thi, Giang Hoang
    Tuyet, Thanh Nham Thi
    Cleland, Charles M.
    Arasteh, Kamyar
    Caniglia, Ellen
    Chen, Yu
    Bart, Gavin
    Moles, Jean Pierre
    Hai, Vinh Vu
    Vallo, Roselyne
    Quillet, Catherine
    Rapoud, Delphine
    Sao, Mai Le
    Michel, Laurent
    Laureillard, Didier
    Khan, Maria R.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2023, 34 (04) : 236 - 244
  • [37] Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study
    Giuseppe Vittorio De Socio
    Elena Ricci
    Giustino Parruti
    Leonardo Calza
    Paolo Maggi
    Benedetto Maurizio Celesia
    Giancarlo Orofino
    Giordano Madeddu
    Canio Martinelli
    Barbara Menzaghi
    Lucia Taramasso
    Giovanni Penco
    Laura Carenzi
    Marco Franzetti
    Paolo Bonfanti
    Infection, 2016, 44 : 589 - 597
  • [38] Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study
    De Socio, Giuseppe Vittorio
    Ricci, Elena
    Parruti, Giustino
    Calza, Leonardo
    Maggi, Paolo
    Celesia, Benedetto Maurizio
    Orofino, Giancarlo
    Madeddu, Giordano
    Martinelli, Canio
    Menzaghi, Barbara
    Taramasso, Lucia
    Penco, Giovanni
    Carenzi, Laura
    Franzetti, Marco
    Bonfanti, Paolo
    INFECTION, 2016, 44 (05) : 589 - 597
  • [39] Effectiveness, persistence and safety of E/C/F/TAF, F/TAF+3rd agent or R/F/TAF use in treatment-naive HIV-1 infected patients: 12-month results from the German TAFNES cohort study
    Heuchel, T.
    Hillenbrand, H.
    Jessen, H.
    Pauli, R.
    Postel, N.
    Haubrich, R.
    Heinzkill, M.
    Goerner, K.
    Stellbrink, H.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [40] Impact of sex work on risk behaviours and their association with HIV positivity among people who inject drugs in Eastern Central Canada: cross-sectional results from an open cohort study
    Cannpeau, Laurence
    Blouin, Karine
    Leclerc, Pascale
    Alary, Michel
    Morissette, Carole
    Blanchette, Caty
    Serhir, Bouchra
    Roy, Elise
    BMJ OPEN, 2018, 8 (01):
12345